Lead poisoning is a serious and very common type of heavy metal poisoning in children in America. The treatment is well recognized by medical authorities around the world. Chelation therapy has already been administered to over 500,000 Americans and over one million Canadians, Europeans, Australians, and South Americans who suffered from hardening of the arteries. It has been given to more than double those numbers for the elimination of heavy metal toxicity. The scientific evidence indicates that a course of EDTA chelation therapy might eliminate the need for bypass surgery.
Chelation has an equally valid rationale for use as preventive treatment.
In 1948, the FDA approved EDTA intravenous chelation as treatment for metal toxicity. EDTA was initially used as a treatment for industrial workers suffering from lead poisoning in a battery factory. Shortly thereafter, the U.S. Navy advocated chelation therapy for sailors who had absorbed lead while painting government ships and other facilities. Physicians then observed that adults receiving chelation treatments who had atherosclerosis also experienced health improvements, diminished angina, and better memory. Chelation therapy is a safe, non-surgical treatment used to rid the body of excess toxins, particularly metals.